Schistosomiasis — Assessing Progress toward the 2020 and 2025 Global Goals

• Published in: The New England journal of medicine Vol. 381; no. 26; pp. 2519 - 2528
• Main Authors: Deol, Arminder K, Fleming, Fiona M, Calvo-Urbano, Beatriz, Walker, Martin, Bucumi, Victor, Gnandou, Issah, Tukahebwa, Edridah M, Jemu, Samuel, Mwingira, Upendo J, Alkohlani, Abdulhakeem, Traoré, Mahamadou, Ruberanziza, Eugene, Touré, Seydou, Basáñez, Maria-Gloria, French, Michael D, Webster, Joanne P
• Format: Journal Article
• Language: English
• Published: United States Massachusetts Medical Society 26.12.2019
• Subjects: Africa South of the Sahara - epidemiology; Age; Animals; Anthelmintics - therapeutic use; Chemotherapy; Child; Communicable Disease Control; Confidence intervals; Control programs; Cross-Sectional Studies; Disease control; Disease prevention; Eggs; Endemic Diseases - prevention & control; Epidemiology; Ethics; Humans; Infections; Morbidity; Organizational Objectives; Prevalence; Public health; R&D; Research & development; Schistosoma haematobium - isolation & purification; Schistosoma mansoni; Schistosoma mansoni - isolation & purification; Schistosomiasis; Schistosomiasis haematobia - drug therapy; Schistosomiasis haematobia - epidemiology; Schistosomiasis haematobia - prevention & control; Schistosomiasis mansoni - drug therapy; Schistosomiasis mansoni - epidemiology; Schistosomiasis mansoni - prevention & control; Tropical diseases; Urine; World Health Organization; Yemen - epidemiology; Africa South of the Sahara; Yemen; Malawi; Uganda
• ISSN: 0028-4793; 1533-4406; 1533-4406
• DOI: 10.1056/NEJMoa1812165

It is estimated that schistosomiasis infects more than 140 million persons globally. In this report, data on the progress of control from nine countries (eight in Sub-Saharan Africa plus Yemen) are presented. Various chemotherapy treatment strategies in countries were analyzed to assess the effect on heavy-intensity infection.